MiMedx Group is based in Marietta, Georgia, and CMS has proposed reimbursement reforms for skin substitutes.
3 reports, 3 independent
Updated Aug 29
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MiMedx Group is based in Marietta, Georgia, and CMS has proposed reimbursement reforms for skin substitutes.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MiMedx
biomedical company based in Marietta, Georgia, founded in 2008
Nothing else this week.
-
Georgia
country in the Caucasus region of Europe and Asia
-
Centers for Medicare and Medicaid Services
United States federal agency
Nothing else this week.
Coverage
Newest first; wire copies grouped- Insider MonkeyMiMedx Group, Inc. (MDXG) Partners with Vaporox for Advanced Wound Therapy We recently published 10 Best Biotech Stocks to Buy Under $10. MiMedx Group, Inc. is placed sixth among them. MiMedx Group,
- TipRanksNorthland sees ‘key positive’ for MiMedx in CMS rule proposal Northland analyst Carl Byrnes says the CMS is taking action to curb skin substitute spending with its 2026 physician fee schedule propose
- Investing.comMiMedx and Organogenesis stocks tumble after CMS proposal to slash spending Investing.com -- MiMedx Group (NASDAQ:MDXG) stock fell 19% and Organogenesis Holdings (NASDAQ:ORGO) shares plunged 36% afte